Compound Detail
CHEMBL451706
CITRACRIDONE I Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL451706 |
| Name | CITRACRIDONE I |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | DIDVBISMWJGFOF-UHFFFAOYSA-N |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
8
Publications
0
Known Names
Molecular Properties
353.4
MW (Da)
3.30
ALogP
6
HBA
2
HBD
80.9
PSA (Ų)
0.66
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 4.9
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MCF7 | IC50 | = | 12500.0 | nM | 4.9 | Antiproliferative activity against human MCF7 cells assessed as reduction in cel... | 35717872 |
| HepG2 | IC50 | = | 12500.0 | nM | 4.9 | Antiproliferative activity against human HepG2 cells assessed as reduction in ce... | 35717872 |
| PC-3 | IC50 | = | 12500.0 | nM | 4.9 | Antiproliferative activity against human PC-3 cells assessed as reduction in cel... | 35717872 |
| A549 | IC50 | = | 12500.0 | nM | 4.9 | Antiproliferative activity against human A549 cells assessed as reduction in cel... | 35717872 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 10217715 | 10.1021/np980504z | A549 | 1 |
| 10217715 | 10.1021/np980504z | B16 | 1 |
| 10217715 | 10.1021/np980504z | CCRF-HSB-2 | 1 |
| 10217715 | 10.1021/np980504z | TGBC11TKB | 1 |
| 35717872 | 10.1016/j.ejmech.2022.114527 | MCF7 | 1 |
| 35717872 | 10.1016/j.ejmech.2022.114527 | HepG2 | 1 |
| 35717872 | 10.1016/j.ejmech.2022.114527 | PC-3 | 1 |
| 35717872 | 10.1016/j.ejmech.2022.114527 | A549 | 1 |
Data from ChEMBL 36 via Core Engine